The Effect of Psidium Guajava Leaf Extract on Cognitive Function in Scopolamine-Induced Alzheimer’s Disease Wistar Rats
Main Article Content
Abstract
This study evaluated the impact of P. guajava leaf extract on cognitive function of scopolamine-induced Alzheimer’s disease model of Wistar rats. The plant leaf was extracted by maceration using methanol as a solvent. Phytochemical screening and quantification of the bioconstituents of the leaf extract were done The study was done in two phases, with phase one lasting for two weeks and phase two lasting for twelve weeks. A total of 80 male Wistar rats weighing 100 – 230 g were divided into 5 groups each for the two phases (phase 1, n = 8; phase 2, n = 8). The rats in groups 2 to 5 were induced with Alzheimer’s disease (AD) using 1 mg/kg of scopolamine (i.p.) for 7 days before commencement of treatment. Group 1 (normal control) received 2 mL/kg of distilled water only, group 2 (AD control rats) also received 2 mL/kg of distilled water while groups 3 – 5 were AD rats treated with 100 mg/kg, 300 mg/kg of P. guajava leaf extract and 5 mg/kg of donepezil respectively. Neurobehavioural tests for cognitive function were done in weeks one and two, then every two weeks using navigational maze test, radial maze test and Barnes maze test. At the end of the14th and 84th days of the experiment, the animals were euthanised with 100 mg/kg of ketamine then decapitated to remove the brain. The brain tissues for the ELISA were rinsed in normal saline, homogenised in phosphate buffer using a ceramic mortar and pestle placed on ice, transferred into sample bottles then taken to the laboratory in ice pack for the BDNF assay. The neurobehavioural results for cognitive function indicated that P. guajava leaf extract significantly (p < 0.05) improved learning and memory in a dose and time dependent manner. The extract was able to improve significantly the levels of BDNF in the brain homogenate. It was concluded from the results that P. guajava leaf may be used in the treatment of AD and it is recommended that the treatment should commence with the low dose (100 mg/kg b.wt.) then progress to the medium dose (300 mg/kg b.wt.).
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Bhattacharya, K., Bhattacharjee, A. & Chakraborty, M. (2024). Assessing the potential of Psidium guajava derived phytoconstituents as anticholinesterase inhibitor to combat Alzheimer’s disease: An in-silico and in-vitro approach, Journal of Biomolecular Structure and Dynamics. Doi:10.1080/07391102.2024.2301930
II. Dakappa, S. S., Adhikari, R., Timilsina, S. S. & Sajjekhan, S. (2013). A review on the medicinal plant Psidium guajava Linn (Myrtaceae). Journal of Drug Delivery and Therapeutics, 3(2): 162 – 168
III. El-Marasy, S. A., Abd-Elsalam, R. M. & Ahmed-Farid, O. A. (2018). Ameliorative effect of silymarin on scopolamine-induced dementia in rats. Open Access Macedonian Journal of Medical Sciences, 6(7): 1215 – 1224. Doi: 10.3889/oamjms.2018.257
IV. Fumagalli, M. & Priori, A. (2012). Functional and clinical neuroanatomy of morality. Brain, 135(7): 2006 – 2021
V. Gutierrez, R. M., Mitchel, L. S., & Soli, R. V. (2008). Psidium guajava: A review of its traditional uses, phytochemistry and pharmacplogy. Journal of Ethnopharmacology, 117(1): 1 – 27
VI. Hock, C., Heese, K., Hulette, C., Rosenberg, C. & Otten, U. (2000). Region-specific neurotrophin imbalance in Alzheimer’s disease: Decreased levels brain-derived neurotrophic factor in hippocampus and cortical areas. Archives Neurology, 57: 846 – 851
VII. Hsiao, Y., Hung, H., Chen, S. & Gean, P. (2014). Social interaction rescues memory deficit in an animal model of Alzheimer’s disease by increasing BDNF-dependent hippocampal neurogenesis. The Journal of Neuroscience, 34(49): 16207 – 16219. Doi: 101523/JNEUOSCI.0747-14.2014
VIII. Huang, E. J. & Reichardt, L. F. (2003). Trk receptors: Roles in neuronal signal transduction. Annual Review Biochemistry, 72: 609 - 642
IX. Lorena, C., Ressaissi, A & Serralheiro, M. L. (2022). Bioactives from Psidium guajava leaf decoction: LC-HRMS-MS-Qtof identification, bioactivities and bioavailability evaluation. Food Chemistry Advances,1:100003Doi:10.1016/j.focha.2021.100003
X. Martin, D. (2015). 9 brain regions affected by Alzheimer’s. www.healthcentral.com/slideshow/9-areas-brain-affected-alzheimer’s.
XI. Okoye, N. (2021). Guava, the sand fruit. www.pharmanewsonline.com/guava-the-sand-fruit/.
XII. Peng, S., Wuu, J., Mufson, E. J. & Fahnestock, M. (2005). Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease. Journal of Neurochemistry, 93(6): 1412 – 1421
XIII. Peris, R. L., Scheuber, M. I., Shan, H., Braun, M. and Schwab, M. E. (2024). Barnes maze test for spatial memory: A new sensitive scoring system for mouse search strategies. Behavioural Brain Research, 458: 114730.
Doi: 10.1016/j.bbr.2023.114730
XIV. Pisani, A., Paciello, F., De Vecchio, Valeria, Malesci, R., De Corso, E., Cantone, E. & Fetoni, A. R. (2023). The role of BDNF as a biomarker in cognitive and sensory neurodegeneration. Journal of Personalized Medicine, 13(4): 652.
Doi: https://doi.org/10.3390/jpm13040652
XV. Pohl, F., Kong, T. & Lin, P. (2018) the potential use of plant natural products and plant extracts with antioxidant properties for the prevention/treatment of neurodegenerative diseases: in vitro, in vivo and clinical trials. Molecules, 23: 3283.
Doi: https://doi.org/10.3390/molecules23123283
XVI. Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J. & Reddy, H. P. (2022). Phosphorylated tau in Alzheimer’s disease and other tauopathies. International Journal of Molecular Sciences, 23(21); 12841. Doi: 10.3390/ijms232112841
XVII. Rojas-Garcia, A., Fernandez-Ochoa, A., Cadiz-Gurrea, L. M., Arraez-Roman, D. & Segura-Carretero, A. (2023). Neuroprotective effects of agri-food by-products rich in phenolic compounds. Nutrients, 15(2): 449.
Doi: https://doi.org/10.3390/nu15020449
XVIII. Rouseff, R. L., Onagbola, E. O., Smoot, J. M. & Stelinski, L. L. (2008). Sulfur volatiles in guava (Psidium guajava L.) leaves: Possible defence mechanism. Journal of Agriculture Food and Chemistry, 56: 8905 – 8910
XIX. Schinder, A. F. & Poo, M. (2000). The neurotrophin hypothesis for synaptic plasticity. Trends Neuroscience, 23(12): 639 – 645.
Doi: 10.1016/s0166-2236(00)01672-6
XX. Shimada, H., Makizako, H., Doi, T., Yoshida, D., Tsut-Sumimoto, K., Anan, Y., Uemura, K., Lee, S., Park, H. & Suzuki, T. (2014). A large cross-sectional observational study of serumBDNF, cognitive function, and mild cognitive impairment in the elderly. Frontier Aging Neuroscience, 6:69.
Doi: 10.3389/fnagi.2014.00069
XXI. Silva, R. F. M. & Pogacnik, L. (2020). Polyphenols from food and natural products: neuroprotective and safety. Antioxidants, 9: 61
XXII. Silva, W. M. B. da, Santos, J. M. dos, Costa, L. de P., Holanda, L. S.de, Andrade Neto, J. B., Batista, A .P., Morais, S M. de, & Souza, C. de M. (2022). Potential of the plant Psidium guajava L. against Alzheimer’s disease by reversing scopolamine-induced memory deficit. Research, Society and Development, 11(14), e234111436167
XXIII. Sofowora, A. (1993). Phytochemical screening of medical plants and traditional medicine in Africa Spectrum Books Ltd, Ibadan, Nigeria
XXIV. Sun, C., Zhang, S., Ba, S., Dang, J., Ren, Q., Zhu, Y, Liu, K. & Jin, M. (2022). Eucommia ulmoides olive male flower extracts ameliorate Alzheimer’s disease-like pathology in zebrafish via regulating autophagy, acetylcholinesterase, and the dopamine transporter. Frontier in Molecular Neuroscience, 15: 901953
XXV. Tarragon, E., Lopez, L., Ros-Bernal, F., Yuste, J. E., Ortiz-Collera, V., Martin, E., Schenker, E., Aujard, F., Bordet, R., Richardson, J. C., & Herrero, M. T. (2012). The radial arm maze (RAM) for the evaluation of working and reference memory deficits in the diurnal rodent Octodondegus. Journal of Experimental Psychology, 2010(2): 97 - 116
XXVI. Te-Hsien, L., Kuo-Hsuan, C., Ya-Jen, C., Zheng-Kui, W., Yin-Chieh, S., Wenwei, L., Guey- Jen, L. & Chiung-Mei, C. (2022). Neuroprotective action of coumarin derivatives through the activation of TRKB-CREB-BDNF pathway and reduction of caspase activity in neuronal cells expressing pro-aggregated tau protein. International Journal of MolecularSciences,23(21):12734.Doi: https://doi.org/10.3390/ijms232112734
XXVII. Trease, G. E. & Evans, W. C. (1989). Pharmacognosy. Ed 11, Brailliar Tiridel can. Macmillian publishers
XXVIII. Usen, D. U. & Enogieru, A. B. (2023). Aluminium Chloride induced prefrontal cortex toxicity in Wistar rats: Evidence from pretreatment with aqueous Psidium guajava leaf extract. Dutse Journal of Pure and Applied Sciences, 9(3): 1 – 10
XXIX. Vijayakumar, K., Rengarajan, R. L., Radhakrishnan, R. & Vijaya, A. A. (2018). Hypolipidemic effect of Psidium guajava leaf extract against hepatotoxicity in rats. Pharmacognosy Magazine, 14(53): 4 - 8
XXX. Walton, M. R. & Dragunow, I. (2000). Is CREB a key to neuronal survival? Trends Neuroscience, 23(2): 48 – 53. Doi: 10.1016/s0166-2236(99)01500-3
XXXI. WHO(2023). Dementia. www.who.int/news-room/fact-sheets/detail/dementia.